Introduction
The role of γ-H2AX in response to cellular exposure to ionising radiation (IR) has been well established whereby phosphorylation on serine 139 of H2AX corresponding to the formation of DNA double strand breaks (DSB) was first identified nearly 15 years ago by Rogakou et al. [1] . The induction of DSB by exposure to IR leads to the predictable induction of γ-H2AX foci in the nuclei of non-lethally irradiated surviving cells, but within a 24-hour period DSB are repaired and γ-H2AX foci are removed. However, in cell lines derived from individuals with defects in DNA DSB repair, such as cells from ataxia telangiectasia patients, Key Words DNA repair · Chemotherapy · Biomarker · Rad51 · γ-H2AX
Abstract
Chemotherapeutic anticancer drugs mediate cytotoxicity by a number of mechanisms. However, alkylating agents which induce DNA interstrand crosslinks (ICL) are amongst the most effective anticancer agents and often form the mainstay of many anticancer therapies. The effectiveness of these drugs can be limited by the development of drug resistance in cancer cells and many studies have demonstrated that alterations in DNA repair kinetics are responsible for drug resistance. In this study we developed two cell lines resistant to the alkylating agents nitrogen mustard (HN2) and cisplatin (Pt). To determine if drug resistance was associated with enhanced ICL DNA repair we used immunocytochemistry and imaging flow cytometry to quantitate the number of γ-H2AX and Rad51 foci in the nuclei of cells after drug exposure. γ-H2AX was used to evaluate DNA strand breaks caused by repair incision nucleases and Rad51 was used to measure the activity of homologous recombination in the repair of ICL. In the drug-resistant derivative cell lines there was overall a significant increase in the number and persistence of both γ-H2AX and Rad51 foci in the nuclei of cells over a 72-hour period, when compared to the non-resistant parental a failure to efficiently repair DSB is associated with a persistence of γ-H2AX foci beyond 24 h [2] . As a result biomarkers of DSB, such as γ-H2AX, potentially lend themselves to the diagnostic setting in the prediction of cancer patient response to clinical radiotherapy (RT). A retrospective study by Bourton et al. [3] , which employed γ-H2AX as a marker of DNA DSB, successfully identified patients who were hypersensitive to RT and experienced severe normal tissue toxicity (NTT). γ-H2AX analysis by flow cytometry revealed a persistence of foci in lymphocytes from patients with severe NTT. Patients that tolerated RT with little or no NTT efficiently repaired DNA DSB with the corresponding reduction in the expression of γ-H2AX foci.
Correspondingly, the use of γ-H2AX and other DNA repair biomarkers might be informative in identifying both patient and tumour response to cytotoxic chemotherapy. Such an approach is challenging given that: (1) chemotherapeutic agents in clinical use have widely different mechanisms of action and may elicit different DNA repair pathways that cannot be monitored by a single DNA repair biomarker; (2) many chemotherapy regimens used for cancer treatment employ a combinatorial approach whereby multiple drugs are used concurrently, and (3) the development of drug resistance in cancer cells may occur by a number of mechanisms that do not involve alteration or modulation of DNA repair pathways, an example here being the development of multiple drug resistance due to p-glycoprotein upregulation [4] .
Despite these caveats, a limited approach to monitoring chemotherapy responses by assessing DNA repair capacity might be both possible and of clinical and experimental benefit. The mainstay of many chemotherapeutic regimens is the use of alkylating agents such as nitrogen mustard (HN2), cyclophosphamide and cisplatin (Pt), which are amongst the most effective chemotherapeutic drugs [5] . Here, cytotoxicity is mediated by the introduction of DNA interstrand crosslinks (ICL) and the degree of cytotoxicity is directly related to their ability to introduce ICL [6] . ICL cause strand distortion and prevent strand dissociation, thus inhibiting DNA synthesis and replication, leading to cell death. Cellular repair of ICL poses a significant challenge to the DNA repair machinery and involves the co-ordinated interaction of distinct DNA repair pathways. In brief, the strand distortion caused by an ICL is recognised by proteins of the Fanconi anaemia (FA) pathway whereby Fanconi-associated nuclease 1 (FAN1) with a 5 ′ -3 ′ exonuclease activity and a 5 ′ -FLAP endonuclease function cleaves the ICL in a process known as 'unhooking'. This converts a stalled replication fork into a one-ended DSB. Other endonucleases, including MUS81-EME1 and XPF-ERCC1, cleave the DNA on the 3 ′ and 5 ′ ends of the ICL, respectively. Subsequently, the strand break caused by the action of the endonucleases creates a substrate which is repaired by homologous recombination (HR) via a Holliday junction pathway mediated by the Rad51 protein [7] . Therefore, in order to monitor this activity in vitro, measuring the level of biomarkers such as γ-H2AX and Rad51 might be valuable. For IR exposure, the appearance of γ-H2AX foci after irradiation is indicative of DNA DSB formation. On the other hand, γ-H2AX foci appearing after treatment with chemotherapeutic agents causing ICL may be reflective of both direct chemotherapy-induced DNA damage or repair processes taking place since γ-H2AX will be activated by the action of nucleases excising the damage [8] . This is further supported by Clingen et al. [9] who demonstrated that repair nucleaseinduced DSB were initiated in both Chinese hamster and human ovarian cancer cells in response to the formation of ICL with a concomitant increase in γ-H2AX foci. Furthermore, the appearance and quantitation of Rad51 foci following exposure to ICL-inducing chemotherapeutic drugs might indicate the extent of DNA repair occurring by HR at the site of DNA damage and the extent of tumour cell resistance or sensitivity to the chemotherapeutic drug.
Development of resistance to chemotherapeutic drugs poses a serious limitation to the effectiveness of treatment [10, 11] . For example, it has been shown that acquired resistance to Pt accounted for treatment failure and deaths in up to 90% of patients with ovarian cancer [12] . Moreover, it has been demonstrated that increased Rad51 expression, evident of HR, is associated with poor treatment outcomes in breast cancer patients [13] .
To evaluate the role of both the γ-H2AX and Rad51 DNA repair biomarkers we employed immunocytochemical methods combined with multispectral imaging flow cytometry to evaluate DNA repair in human cells resistant and sensitive to the crosslinking agents HN2 and Pt. We demonstrated that in cell lines resistant to these drugs there was in general elevated and persistent expression of γ-H2AX and Rad51 foci in the nuclei of cells. These data indicate that evaluation of these biomarkers in both normal and tumour cells may predict patient response to therapy and determine mechanisms of patient resistance to treatment.
Materials and Methods

Cell Lines
Immortalised human fibroblast cell lines derived from normal and DNA repair-defective individuals, as well as two ovarian cancer cell lines from an untreated cancer patient, were selected for this study. Details of these cell lines are provided in table 1 . The A2780 ovarian cancer cell line was derived from an untreated cancer patient. The A2780 Pt-resistant variant was used for this study where Pt resistance was created by chronic exposure to Pt independently of our laboratory. These cell lines were obtained from the European Collection of Cell Cultures (ECACC; Porton Down, UK).
Cell Culture
The MR5-SV1 and NB1-tert cells were routinely cultured in Dulbecco's Modified Eagle Medium (PAA Laboratories Ltd., Yeovil, UK) which was supplemented with 10% foetal calf serum, 2 m M L -glutamine and 100 units/ml of penicillin and streptomycin (PAA Laboratories Ltd.). Cells were grown in 100-mm Petri dishes (Sarstedt Ltd., Leicester, UK) as monolayers at 37 ° C in a humidified atmosphere of 5% CO 2 in air. The ovarian cancer cell lines A2780 were cultured in a similar manner but in RPMI 1640 medium in a temperature-controlled laboratory within a Heraeus Class II Laminar Flow hood.
Development of Cell Lines Resistant to HN2 and Pt
Two DNA repair normal cell lines, MRC5-SV1 and NB1-HTERT, were selected to develop cell lines resistant to HN2. IC 50 values, defined as the concentration of drug that kills approximately 50% of the cell population after 1 h of exposure to each chemotherapeutic agent, were derived for the two cell lines using clonogenic assays. These concentrations provided a starting point for drug treatment and development of resistance. The cell lines were continuously exposed to 0.50 μg/ml of HN2 (Sigma Aldrich Ltd., Gillingham, UK) in culture medium until they reached confluency. Cells were then sub-cultured and exposed to a higher concentration of HN2. This concentration was increased by a geometric ratio of 1.5-fold of the previous concentration (i.e. 0.50 μg/ml was increased to 0.75 μg/ml). Cells were continuously exposed to HN2 until they reached a concentration of drug that was 10-fold of their respective IC 50 values (3.50 μg/ml for NB1-HTERT R and 5.30 μg/ ml for MRC5-SV1 R ).
The A2780Cis cell line was developed through continual exposure of the A2780 parental cell line to Pt. This cell line was obtained from the ECACC.
Induction of ICL in Cell Lines by Drug Exposure
To monitor the induction of ICL by drug exposure, cells were first exposed to an IC 50 drug concentration. This was followed by immunological detection of γ-H2AX and Rad51 foci. The IC 50 used for both sensitive and resistant derivatives was derived from clonogenic assays of the parental cells to allow for meaningful comparisons. IC 50 values for HN2 was 0.30 μg/ml for NB1-HTERT cells (parent and resistant) and 0.50 μg/ml for MRC5-SV1 cells (parent and resistant). For Pt, the IC 50 concentration was 12.00 μg/ ml for the MRC5-SV1 cell line and 6.00 μg/ml for NB1-HTERT cells. All cell lines as proliferating monolayers and at approximately 80% confluency were treated for 1 h with the IC 50 drug concentration. For the A2780 and A2780 Pt resistance cell lines, cells were exposed to 0.50 μg/ml of HN2 in a similar manner to the MRC-SV1 cells.
Immunocytochemistry to Detect γ-H2AX and Rad51 Foci
Immunocytochemistry was carried out as detailed in Bourton et al. [16] . Untreated cells and those exposed to HN2 were fixed in 50: 50 methanol:acetone (v/v) at 3, 5, 24, 30 and 48 h after treatment with HN2. For Pt exposures, the fixation time points were 6, 12, 24, 30, 48 and 72 h after treatment. Cells were blocked using 10% rabbit serum (PAA Laboratories Ltd.) in phosphate-buffered saline pH 7.4 (Severn Biotech, Kidderminster, UK) and stained with a mouse monoclonal anti-serine 139 γ-H2AX antibody (Clone JBW 301; Millipore UK Ltd., Watford, UK) at 1: 10,000 dilution in block buffer. Cells were then counterstained with Alexa Fluor 488 (AF 488 ) rabbit anti-mouse IgG (Life Technologies, Paisley, UK) at 1: 1,000 
Imaging Flow Cytometry
Imaging flow cytometry was conducted using the Imagestream X (Amnis Inc., Seattle, Wash., USA) which can capture images on up to six optical channels. Following excitation with a 488-nm laser, images of each individual cell were captured using a 40× objective on Channel 1 for brightfield (BF), Channel 2 for AF 488 , which represents the green staining of γ-H2AX and Rad51 foci, and on Channel 5 for Draq5 staining, which represents the nuclear region of each cell. Images were acquired at a rate of approximately 100 images per second and 10,000 images were captured for each sample at each time point.
Image Compensation
Compensation was performed on populations of cells that had been fixed 24 h after treatment with either HN2 or Pt due to the intensity of γ-H2AX and Rad51 likely being the highest in these samples. Cells were stained with either AF 488 or Draq5 and images were captured using the 488-nm laser as the sole source of illumination. The IDEAS ® analysis software compensation wizard generates a table of coefficients whereby detected light displayed by each image is placed into the proper channel (Channel 2 for AF 488 and Channel 5 for Draq5) on a pixel-by-pixel basis. The coefficients were normalised to 1 and each coefficient represents the leakage of fluorescent signal into juxtaposed channels. This compensation matrix was then applied to all subsequent analyses.
Analysis of Cell Images and γ-H2Ax or Rad51
Foci Number Calculation γ-H2AX foci were quantified using the IDEAS ® analysis software. Foci were quantified in a similar manner as previously described in Bourton et al. [16] . In brief, a series of predefined 'building blocks' provided within the software distinguished the population of single cells that were in the correct focal plane. Two truth populations with a minimum of 40 cells were then identified by the operator, one to represent low numbers of foci (less than 2) and the other representing cells with high numbers of foci (greater than 5-6). The populations were selected to encompass the range of staining achieved (i.e. weakly stained cells to bleached cells) which permitted the software to select the most sensitive mask that accurately enumerated the foci.
Statistical Analysis
Statistical analysis was carried out using the data analysis feature in Microsoft Excel. Two-way analysis of variance was used to compare the distribution of foci in drug-resistant and parental cell lines following exposure to the chemotherapeutic agents HN2 and Pt. This was carried out across the whole time course of the experiment with a p value <0.001 being considered as significant.
Results
Cellular Sensitivity to HN2 and Pt
Clonogenic assays were carried out on all cell lines after exposure to increasing concentrations of HN2 ( fig. 1 a) and Pt ( fig. 1 b) to determine cellular sensitivity to these drugs. It was observed that the MRC5-SV1 R cell line had an IC 50 value of 1.40 μg/ml in response to treatment with HN2. This was a 3-fold increase in resistance when com- pared to the MRC5-SV1 cell line, the IC 50 value of which was 0.50 μg/ml. The NB1-HTERT R cell line showed a 2.7-fold increase in resistance to HN2 in comparison to the NB1-HTERT cell line with IC 50 values of 0.82 and 0.30 μg/ml, respectively. Both HN2-resistant cell lines also displayed cross-resistance to Pt. The MRC5-SV1 R cell line had an IC 50 value of 23.00 μg/ml in comparison to 12.00 μg/ml seen in the parental cell line, thus exhibiting an approximate 2-fold resistance to Pt. The NB1-HTERT cell line had an IC 50 of 6.00 μg/ml whilst the NB1-HTERT R cell line had an IC 50 of 19.00 μg/ml Pt, demonstrating a 3-fold resistance. Therefore, resistance to HN2 and crossresistance to Pt was induced in the MRC5-SV1 R and NB1-HTERT R cell lines. As expected, the GM08437B cell line showed an increased sensitivity to HN2 in comparison to all other cell lines observed with an IC 50 value of 0.20 μg/ ml for HN2. However, it was seen to have a similar sensitivity to Pt as the NB1-HTERT cell line with an IC 50 value of 7.00 μg/ml.
DNA Repair Assays
To determine if drug resistance was associated with elevated γ-H2AX or Rad51 foci expression, foci numbers were quantified at different time points over a maximum of 72 h after 1 h of exposure to either HN2 or Pt ( fig. 2-5 ). 
γ-H2AX Foci Induction in MRC5-SV1, MRC5-SV1 R , A2780 and A2780Cis Following HN2 Treatment
Average γ-H2AX foci induction was determined in the MRC5-SV1 and MRC5-SV1 R cell lines after 1 h of treatment with 0.50 μg/ml HN2 over a 48-hour period ( fig. 2 a) . Foci images were analysed and quantified using the Imagestream X and enumerated by applying a morphology and peak mask as previously described in Bourton et al. [16] .
The MRC5-SV1 parental cell line exhibited fewer γ-H2AX foci compared to the MRC5-SV1 R cell line in the majority of the time points sampled. In MRC5-SV1-untreated cells, an average of 2.28 foci per cell was observed while the MRC5-SV1 cell line showed an average of 10.98 foci per cell. At 24 h, there was a clear increase in foci induction in the MRC5-SV1 cell line with an average of 13.51 foci per cell. By 48 h, the level of γ-H2AX foci decreased dramatically to 3.67 foci per cell. However, the MRC5-SV1 R cell line did not exhibit any dramatic fluctuations in foci number over the same time period with an average of 12.04 and 13.38 foci seen at 24 and 48 h, respectively.
Average γ-H2AX foci induction was also determined in the A2780 and A2780cis R cell lines after 1 h of treatment with 0.50 μg/ml of HN2 over a 48-hour period ( fig. 2 a) . The A2780 parental cell line also exhibited peak γ-H2AX foci formation at 24 h, averaging 5.67 foci per cell. This was a 2.25-fold increase from the untreated controls, which showed an average of 2.56 foci per cell. The A2780cis R cell line had similar levels of foci in the earlier time points to the A2780 cell line with an average of 3.515 foci per cell, but at 24 and 30 h foci formation had nearly tripled in comparison to the untreated control, with an average of 10.39 and 9.67 foci seen, respectively.
Rad51 Foci Induction in MRC5-SV1 and MRC5-SV1
R Following HN2 Treatment Average Rad51 foci induction was determined in the MRC5-SV1, MRC5-SV1 R , A2780 and A2780Cis cell lines after 1 h of treatment with 0.50 μg/ml HN2 ( fig. 2 b) . The MRC5-SV1 cell line showed fewer Rad51 foci than the MRC5-SV1
R cell line at all time points examined. There was a 3.7-fold difference seen between the untreated controls of the two cell lines with an average of 11.57 foci seen in the MRC5-SV1 R cell line and 3.16 foci seen in the parental cell line. This difference in RAD51 foci induction was maintained at all time points tested up to 48 h with 
γ-H2AX Foci Induction in NB1-HTERT, NB1-HTERT R and GM08437B Following HN2 Treatment
The NB1-HTERT, NB1-HTERT R and GM08437B cell lines were exposed to 0.30 μg/ml HN2 for 1 h and γ-H2AX foci induction was observed in these cells lines over a 48-hour period ( fig. 3 a) . The NB1-HTERT cell line showed a lower number of γ-H2AX foci across the whole time period in comparison to the NB1-HTERT R cell line. In the NB1-HTERT cell line the untreated control displayed an average of 5.00 foci per cell. A modest induction of γ-H2AX foci was shown at 24 h with an average of 7.50 foci per cell, which then decreased to 3.70 foci per cell at 48 h. In contrast, the NB1-HTERT R cell line had an average of 6.90 foci in the untreated control which increased to 8.08 foci per cell at 24 h. Retention of foci was seen at 48 h with an average of 8.10 foci per cell. Surprisingly, the GM08347B (XPF deficient) cell line showed the highest induction of γ-H2AX foci at 24 h with an average of 13.60 foci per cell in comparison to an average of 5.70 foci per cell seen in the untreated control. Foci retention was observed at 48 h in this cell line with an average of 8.70 foci per cell.
Rad51 Foci Induction in NB1-HTERT, NB1-HTERT R and GM08437B Following HN2 Treatment
Average Rad51 foci numbers were calculated in the same cell lines after treatment with HN2 ( fig. 3 b) . The untreated control of the NB1-HTERT cell line exhibited 4.18 foci per cell which then moderately increased to 5.89 foci per cell at 24 h. This was then seen to decrease to 5.37 foci per cell at 48 h. In the NB1-HTERT R cell line, foci numbers were slightly lower and untreated control cells exhibited 1.56 foci per cell. This increased to 2.37 and 3.36 foci per cell at 24 and 48 h, respectively. The GM08347B cell line showed higher numbers of Rad51 foci in untreated control and drug-treated cells at all time points when compared to the NB1-HTERT and NB1-HTERT R cell lines (ANOVA p < 0.0001). This observation largely mimics that displayed with the γ-H2AX biomarker using the same cell lines.
γ-H2AX Foci Induction in MRC5-SV1 and MRC5-SV1
R Following Pt Treatment Average γ-H2AX foci were enumerated in the MRC5-SV1 and MRC5-SV1 R cell lines after 1 h of treatment with 12 μg/ml Pt ( fig. 4 a) . Similar results were yielded for γ-H2AX expression levels after treatment with Pt compared to those obtained using HN2 treatment in these cell lines. It was observed that the MRC5-SV1 R cell line showed an increased level of γ-H2AX foci at every time point sampled. For example, in untreated controls there were 4.96 foci per cell in the MRC5-SV1 cell line but 17.08 foci in the MRC5-SV1 R cell line. The MRC5-SV1 cell line exhibited a peak of γ-H2AX foci formation at 24 h with an average of 7.78 foci per cell, which was then seen to decline at 72 h to 6.06 foci per cell. The MRC5-SV1 R cell line showed very little increase in foci induction with peak foci induction seen at 30 h averaging 19.92 foci, which decreased to 18.47 foci per cell at 72 h.
Rad51 Foci Induction in MRC5-SV1 and MRC5-SV1 R Following Pt Treatment
After treatment with 12 μg/ml Pt, an increase in Rad51 expression was seen in the MRC5-SV1
R cell line at all time points in comparison to the MRC5-SV1 cell line ( fig. 4 b) . Rad51 foci formation also peaked at 30 h in the GM08347B cell line with an average of 12.51 foci per cell. At 48 h, Rad51 levels in the NB1-HTERT and NB1-HTERT R decreased to similar levels as exhibited in their respective untreated controls but foci levels remained high in the GM08437B cell line. Statistical analysis using ANOVA revealed significant differences in foci induction between the cell lines at all time points tested (p < 0.0001). Figure 6 shows representative examples of increasing foci number for γ-H2AX ( fig. 6 a) and Rad51 ( fig. 6 b) . Images of cells are shown in BF on Channel 1 while the foci stained with AF 488 are shown in Channel 2. The third col- umn depicts the spot mask (overlaid in cyan) created to enumerate foci and, finally, a Draq 5-stained image of the cell nuclei is shown on Channel 5.
Discussion
This study examined the DNA damage response of different cell lines to the crosslinking chemotherapeutic agents HN2 and Pt by analysing γ-H2AX and Rad51 foci induction over a maximum time period of 72 h. Three of the cell lines, MRC5-SV1, A2780 and NB1-HTERT, were repair normal with no known DNA repair defects. Two cell lines resistant to the crosslinking agents HN2 and Pt were created in our lab, namely MRC5-SV1 R and NB1-HTERT R . A third cell line, A2780cis R , was created in a similar manner independently of our lab.
In response to treatment with HN2 and Pt, which are effective at inducing ICL, γ-H2AX foci formation indicate repair nuclease incisions being made during the resolution of DNA damage. In broad terms, we demonstrated that in cell lines exhibiting resistance to HN2 and Pt there was an elevated induction of γ-H2AX foci at most time points sampled. This increased foci induction is consistent with DNA strand breaks created by the action of DNA repair endonucleases removing the ICL from the DNA. This reasoning is supported by in vitro studies from, for example, Clingen et al. [17] and Niedernhofer et al. [18] , who have shown the accumulation of γ-H2AX foci in the nuclei of cells following exposure to Pt and mitomycin C which mediate cytotoxicity via ICL induction in the DNA.
Treatment with both HN2 and Pt revealed increased Rad51 foci levels in one of the resistant cell lines, MRC5-SV1 R , in comparison with its parental cell line (MRC5-SV1). Since HR is known to have a critical role in completing repair of ICL, the increased Rad51 foci levels is indicative of an upregulation of the HR pathway in this cell line. Interestingly, the other two cell lines NB1-HTERT R and A2780cis R did not consistently show increased Rad51 foci levels after treatment with HN2 and Pt. This may indicate that these cell lines might have acquired drug resistance through other mechanisms. For example, increased tolerance to the formation of DNA breaks caused by incision nucleases may account for the low Rad51 foci levels but high γ-H2AX foci levels observed in the NB1-HTERT R cell line. The observations obtained with the GM08437B (XPF defective cell line) is prima facie, inconsistent with the hypothesis that increased γ-H2AX and Rad51 expression is associated with elevated DNA repair. We demonstrated that this cell line was hypersensitive to the lethal effects of both drugs in a clonogenic assay. Moreover, we have asserted that high foci levels are associated with both increased repair incision activity and elevated HR in the drug-resistant and normal cell lines. Other studies have also shown that cells deficient in either ERCC1 or XPF render them highly sensitive to ICL agents [9, [18] [19] [20] [21] . The XPF-ERCC1 site-specific endonuclease is an important heterodimer in the repair of ICL where the heterodimer 'unhooks' ICL by making dual cuts on one strand of the crosslinked DNA, thus initiating the repair process of ICL [9, 19] . However, it has also been demonstrated that ERCC1-deficient cells can induce γ-H2AX foci formation where ICL-induced DSB formation was independent of the XPF-ERCC1 endonuclease [18, 22] . This correlates with findings in this study which showed that the GM08437B cell line, deficient in XPF, also induced γ-H2AX formation at very high levels. We propose that retention of both γ-H2AX and Rad51 foci seen in the GM08437B cell line is due to stalled DNA repair due to the defective XPF-ERCC1 excision nuclease.
Recent studies have revealed that 15 genes belonging to the FA pathway play a vital role in the maintenance of genomic stability [23] and have a central role in ICL repair. They are involved in the co-ordination of multiple repair processes, particularly nucleases that are vital for incising the ICL. Bhagwat et al. [22] demonstrated that the MUS81-EME1 heterodimer endonuclease, recruited by various FA proteins, makes the initial incision at the site of the crosslink, thereby creating a DSB. XPF-ERCC1 then makes the second incision, resulting in the 'unhooking' of the crosslink. This may provide an explanation for the induction of γ-H2AX foci in the XPF-deficient cell line where the defective XPF-ERCC1 endonuclease cannot complete the repair, thus leaving residual DSB and a high γ-H2AX signal.
To summarise, we have developed drug resistance to HN2 and Pt in two human immortalised cell lines, MRC5-SV1 and NB1-Tert. We used two DNA repair biomarkers, γ-H2AX to monitor repair incision nuclease activity and Rad51 to monitor HR activation, and have shown that, in general, alterations in the dynamics and level of DNA repair of ICL may partly account for the elevated resistance to these drugs. In addition, in a pair of ovarian cancer cell lines, A2780 and A2780cis R , we observed an increase in the activity of the γ-H2AX biomarker in the resistant variant following exposure to the crosslinking agent HN2. Our data suggest that in all drug-resistant cells there is a consistent increase in the level of the γ-H2AX biomarker, which points to an increase in the excision of crosslinks. For Rad51 the situation is less distinct whereby modest increases and decreases in the expression of this biomarker are observed in the cell lines independent of drug resistance.
We conclude that these biomarkers may prove useful in providing a mechanistic understanding of induced drug resistance in those cases where alterations in DNA repair dynamics underlies the response. The application of such biomarkers may be particularly appropriate in cancers, such as ovarian cancer, where treatment failure due to drug resistance is a major issue in clinical management [12] . However, we concede that to exclusively focus on DNA repair as a mechanism of drug resistance in cancer would be naïve given that drug resistance can occur by a number of mutually exclusive cellular mechanisms. Notwithstanding, a comprehensive analysis of DNA repair kinetics in drug-resistant human cell lines and tumours using γ-H2AX and Rad51 (and other) DNA repair biomarkers may prove useful in identifying cancers where inhibition of specific DNA repair pathways may be of significant clinical benefit.
